Stealth Biotherapeutics Corp ADR (MITO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,834 | 47,135 | 42,277 | 30,766 | 32,060 |
| TOTAL | $36,400 | $49,602 | $43,440 | $31,610 | $33,987 |
| Non-Current Assets | |||||
| PPE Net | 88 | 97 | 115 | 72 | 92 |
| Other Non-Current Assets | 427 | 527 | 632 | 576 | 702 |
| TOTAL | $515 | $624 | $747 | $648 | $794 |
| Total Assets | $36,915 | $50,226 | $44,187 | $32,258 | $34,781 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 5,452 | 7,236 |
| Accounts payable and accrued liabilities | 4,122 | 3,467 | 3,915 | 2,566 | 4,620 |
| Accrued Expenses | 5,767 | 7,361 | 5,743 | 5,397 | 4,350 |
| TOTAL | $9,889 | $10,828 | $9,658 | $13,415 | $16,206 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,782 | 13,656 | 13,542 | 6 | 11 |
| Other Non-Current Liabilities | 65,561 | 71,037 | 49,819 | 45,152 | 30,643 |
| TOTAL | $79,343 | $84,693 | $63,361 | $45,158 | $30,654 |
| Total Liabilities | $89,232 | $95,521 | $73,019 | $58,573 | $46,860 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 207 | N/A |
| Retained earnings | N/A | N/A | N/A | -581,549 | N/A |
| Other shareholders' equity | -52,317 | -45,295 | -28,832 | 0 | -12,079 |
| TOTAL | $-52,317 | $-45,295 | $-28,832 | $-26,315 | $-12,079 |
| Total Liabilities And Equity | $36,915 | $50,226 | $44,187 | $32,258 | $34,781 |